Evidence map›Paper›PMID 31041693›Full record

ArticleNeuroscience bulletin2019

Increased CXCL13 and CXCR5 in Anterior Cingulate Cortex Contributes to Neuropathic Pain-Related Conditioned Place Aversion.

Xiao-Bo Wu, Li-Na He, Bao-Chun Jiang, Xue Wang, Ying Lu, Yong-Jing Gao

Open access · greenAbstract read
In one paragraph

Article in Neuroscience bulletin, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Review
  3. CXCL13/CXCR5: a new target for pain treatment.International journal of surgery (London, England) · 2025
    Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Xiao-Bo WuInstitute of Pain Medicine, Institute of Special Environmental Medicine, Nantong University, Nantong, 226019, China.
Li-Na HeInstitute of Pain Medicine, Institute of Special Environmental Medicine, Nantong University, Nantong, 226019, China.
Bao-Chun JiangInstitute of Pain Medicine, Institute of Special Environmental Medicine, Nantong University, Nantong, 226019, China.
Xue WangInstitute of Pain Medicine, Institute of Special Environmental Medicine, Nantong University, Nantong, 226019, China.
Ying LuDepartment of Nutrition and Food Hygiene, School of Public Health, Nantong University, Nantong, 226019, China.
Yong-Jing GaoInstitute of Pain Medicine, Institute of Special Environmental Medicine, Nantong University, Nantong, 226019, China. gaoyongjing@ntu.edu.cn.
Nantong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pain consists of sensory-discriminative and emotional-affective components. The anterior cingulate cortex (ACC) is a critical brain area in mediating the affective pain. However, the molecular mechanisms involved remain largely unknown. Our recent study indicated that C-X-C motif chemokine 13 (CXCL13) and its sole receptor CXCR5 are involved in sensory sensitization in the spinal cord after spinal nerve ligation (SNL). Whether CXCL13/CXCR5 signaling in the ACC contributes to the pathogenesis of pain-related aversion remains unknown. Here, we showed that SNL increased the CXCL13 level and CXCR5 expression in the ACC after SNL. Knockdown of CXCR5 by microinjection of Cxcr5 shRNA into the ACC did not affect SNL-induced mechanical allodynia but effectively alleviated neuropathic pain-related place avoidance behavior. Furthermore, electrophysiological recording from layer II-III neurons in the ACC showed that SNL increased the frequency and amplitude of spontaneous excitatory postsynaptic currents (sEPSCs), decreased the EPSC paired-pulse ratio, and increased the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor/N-methyl-D-aspartate receptor ratio, indicating enhanced glutamatergic synaptic transmission. Finally, superfusion of CXCL13 onto ACC slices increased the frequency and amplitude of spontaneous EPSCs. Pre-injection of Cxcr5 shRNA into the ACC reduced the increase in glutamatergic synaptic transmission induced by SNL. Collectively, these results suggest that CXCL13/CXCR5 signaling in the ACC is involved in neuropathic pain-related aversion via synaptic potentiation.

Indexed as

AnimalsChemokine CXCL13Conditioning, PsychologicalExcitatory Postsynaptic PotentialsGlutamatesGyrus CinguliHyperalgesiaLigationMaleMiceMice, Inbred ICRNeuralgiaReceptors, CXCR5Signal TransductionSpinal CordSpinal Nerve RootsChemokine CXCL13Cxcl13 protein, mouseCXCR5 protein, mouseGlutamatesReceptors, CXCR5Anterior cingulate cortexConditioned place aversionCXCL13CXCR5Neuropathic painSynaptic transmission

Identifiers

PMID31041693
PMCPMC6616612
OpenAlexW2943623827

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.